Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients

Background: Programmed cell death 1 ligand-1 (PD-L1) is an immune checkpoint molecule that acts to protect cancer cells from immune surveillance and is considered as a prognostic biomarker in several cancers, but the prognostic value of PD-L1 in bone and soft tissue sarcomas remains inconclusive. In...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Feng Wang, Tao Yu, Chengbin Ma, Hongmou Yuan, Haifei Zhang, Zhiyu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Subjects:	programmed cell death 1 ligand-1 sarcoma meta-analysis prognosis overall survival
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00749/full